| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.4 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |